Ademi LLP is investigating Akoya (NASDAQ: AKYA) for possible breaches of fiduciary duty and other violations of law in its transaction with Quanterix.
In the transaction, Akoya stockholders will receive only 0.318 shares of Quanterix common stock for each share of Akoya common stock owned. Akoya insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Akoya by imposing a significant penalty if Akoya accepts a competing bid. We are investigating the conduct of Akoya’ board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.